[HTML][HTML] Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs …

AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …

Rehabilitation of patients with COVID-19

T Sun, L Guo, F Tian, T Dai, X Xing… - Expert review of …, 2020 - Taylor & Francis
Introduction In 2020, due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-
2), coronavirus disease (COVID-19) has become a pandemic. As of 11 August 2020, the …

Weathering the cytokine storm in COVID-19: therapeutic implications

G Iannaccone, R Scacciavillani, MG Del Buono… - Cardiorenal …, 2020 - karger.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently
emerged in Wuhan, Hubei-China, as responsible for the coronavirus disease 2019 (COVID …

[HTML][HTML] Mesenchymal stem cells: current clinical progress in ARDS and COVID-19

K Xiao, F Hou, X Huang, B Li, ZR Qian, L Xie - Stem Cell Research & …, 2020 - Springer
Acute respiratory distress syndrome (ARDS) develops rapidly and has a high mortality rate.
Survivors usually have low quality of life. Current clinical management strategies are …

Harnessing the therapeutic potential of extracellular vesicles for biomedical applications using multifunctional magnetic nanomaterials

L Yang, KD Patel, C Rathnam, R Thangam, Y Hou… - Small, 2022 - Wiley Online Library
Extracellular vesicles (eg, exosomes) carrying various biomolecules (eg, proteins, lipids,
and nucleic acids) have rapidly emerged as promising platforms for many biomedical …

[HTML][HTML] Regulatory immune cells in idiopathic pulmonary fibrosis: friends or foes?

C van Geffen, A Deißler, M Quante, H Renz… - Frontiers in …, 2021 - frontiersin.org
The immune system is receiving increasing attention for interstitial lung diseases, as
knowledge on its role in fibrosis development and response to therapies is expanding …

[HTML][HTML] A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report

H Peng, T Gong, X Huang, X Sun, H Luo… - Stem Cell Research & …, 2020 - Springer
Acute respiratory distress syndrome virus-2 (SARS-CoV-2) responsible for coronavirus
disease 2019 (COVID-19) infection, which causes global public health emergencies, has …

[HTML][HTML] Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product …

PS Couto, N Al-Arawe, IS Filgueiras… - Frontiers in …, 2023 - frontiersin.org
During the pandemic of severe respiratory distress syndrome coronavirus 2 (SARS-CoV2),
many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) …

Stem cell therapy for COVID‐19: Possibilities and challenges

MS Choudhery, DT Harris - Cell biology international, 2020 - Wiley Online Library
Since its eruption in China, novel coronavirus disease (COVID‐19) has been reported in
most of the countries and territories (> 200) of the world with∼ 18 million confirmed cases …

COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: potential targets and challenges

A Pourgholaminejad… - Scandinavian Journal …, 2022 - Wiley Online Library
The role of the immune system against coronavirus disease 2019 (COVID‐19) is unknown in
many aspects, and the protective or pathologic mechanisms of the immune response are …